Fairness opinions › Acquirers
Warburg Pincus: healthcare acquisitions with fairness opinions
2 public-company targets, 2010-2011, $885M combined enterprise value. The multiples Warburg Pincus paid and the banker analyses behind each target board's recommendation.
Deals
2
Median EV / EBITDA paid
10.5x
Median EV / revenue paid
1.04x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2011-03-28 | Rural/Metro | Warburg Pincus | Medical Transportation | $658M | 8.6x | 1.20x | 11.5%–12.5% | RBC Capital Markets, Moelis & Company |
| 2010-12-27 | ReSearch Pharmaceutical Services | Warburg Pincus | Pharmaceutical Services | $227M | 12.4x | 0.89x | 12.0%–13.0% | Jefferies |